HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin-like growth factor-I protects granule neurons from apoptosis and improves ataxia in weaver mice.

Abstract
Most cerebellar granule neurons in weaver mice undergo premature apoptosis during the first 3 postnatal weeks, subsequently leading to severe ataxia. The death of these granule neurons appears to result from a point mutation in the GIRK2 gene, which encodes a G protein-activated, inwardly rectifying K+ channel protein. Although the genetic defect was identified, the molecular mechanism by which the mutant K+ channel selectively attacks granule neurons in weaver mice is unclear. Before their demise, weaver granule neurons express abnormally high levels of insulin-like growth factor (IGF) binding protein 5 (IGFBP5). IGF-I is essential for the survival of cerebellar neurons during their differentiation. Because IGFBP5 has the capacity to block IGF-I activity, we hypothesized that reduced IGF-I availability resulting from excess IGFBP5 accelerates the apoptosis of weaver granule neurons. We found that, consistently with this hypothesis, exogenous IGF-I partially protected cultured weaver granule neurons from apoptosis by activating Akt and decreasing caspase-3 activity. To determine whether IGF-I protects granule neurons in vivo, we cross-bred weaver mice with transgenic mice that overexpress IGF-I in the cerebellum. The cerebellar volume was increased in weaver mice carrying the IGF-I transgene, predominantly because of an increased number of surviving granule neurons. The presence of the IGF-I transgene resulted in improved muscle strength and a reduction in ataxia, indicating that the surviving granule neurons are functionally integrated into the cerebellar neuronal circuitry. These results confirm our previous suggestion that a lack of IGF-I activity contributes to apoptosis of weaver granule neurons in vivo and supports IGF-I's potential therapeutic use in neurodegenerative disease.
AuthorsJin Zhong, Jixian Deng, Jennifer Phan, Stephen Dlouhy, Huangbing Wu, Weiguo Yao, Ping Ye, A Joseph D'Ercole, Wei-Hua Lee
JournalJournal of neuroscience research (J Neurosci Res) Vol. 80 Issue 4 Pg. 481-90 (May 15 2005) ISSN: 0360-4012 [Print] United States
PMID15846777 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Insulin-Like Growth Factor I
  • DNA Polymerase I
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
  • Bromodeoxyuridine
Topics
  • Age Factors
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Ataxia (pathology, physiopathology)
  • Behavior, Animal
  • Bromodeoxyuridine
  • Caspase 3
  • Caspases (metabolism)
  • Cell Count (methods)
  • Cerebellum (cytology)
  • DNA Polymerase I (metabolism)
  • Gene Expression Regulation, Developmental
  • In Situ Hybridization (methods)
  • Insulin-Like Growth Factor I (genetics, pharmacology)
  • Mice
  • Mice, Neurologic Mutants
  • Mice, Transgenic
  • Motor Activity (drug effects, physiology)
  • Neurons (cytology, drug effects)
  • Psychomotor Performance (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: